ATIpPharmacologypProctorp2023pfinalpexampwithpcorrectpanswers
1. Whatp is/arep thep action(s)p ofp thep drugp metformin?
a. Decreasesp Hepaticp glucosep productionp andp intestinalp glucosep absorption
b. Increasesp sensitivityp top insulin
c. Shortptermpsedation
d. BothpApand:pd.pBothpApandpB
a. DecreasespHepaticpglucosepproductionpandpintestinalpglucosepabsorption
b. Increasespsensitivityptopinsulin
2. Whenp administeringp thep drugp sennap top ap patient,p ap healthp carep provider
p mustpinformptheppatientpofpwhichpofpthepfollowing
A. Thisp drugp isp intendedp top lowerp bloodp pressurep andp isp bestp
usedp inpcombination
withpotherpantihypertensives
b. Thispdrugpispnotpintendedpforplongptermpuse
c. Theppatientpmustplimitphis/herpfiberpintake
d. Advisep patientp top changep positionsp slowlyp top limitp thep ri
skp ofporthostaticphypotensionp-
:pb.pThispdrugpispnotpintendedpforplongptermpuse
3. Whenpgivingpdigoxinp(Lanoxin)ptopappatient,pthephealthpcarepproviderpnotic
espvariousp signsp andp symptomsp ofp anp overdose.p Thep healthp carep provid
erp knowspto
givep whichp ofp thep followingp top reversep digoxinp toxicity
a. Naloxone
b. VitaminpK
c. Digibind
,d. Fluemanzilp-:pc.pDigibind
4. WhilepprovidingpanpAngiotensin-
convertingpenzymep(ACE)pinhibitor,ptheppa-ptient
asks
4. whatpthepactionpofpthepdrugpis.pAspaphealthp carepprovider,p youpexplain
pthatpthepactionpofpanpACEpinhibitorpis
a. Top lowerp bloodp pressurep byp blockingp thep conversionp ofp angioten
sinp IptopvasoconstrictorpangiotensinpII
, b. Topinhibitpreabsorptionpofpsodiumpbackpintopthepbody,pultimatelypincr
easingpurinepoutputpandploweringpbloodppressure
c. Top decreasep heartp ratep andp bloodp pressurep byp competingp withp Beta
1p andpBeta2preceptorspinpthepheartpandplungs
d. Toplowerpbloodpglucosepbypstimulatingpthepreleasepofpinsulinp-
:pa.pToplowerpbloodppressurepbypblockingpthepconversionpofpangiotensinpIptopvasoconstrictor
angiotensinpII
5. Whichp ofp thep followingp typesp ofp insulinp isp "long-acting"?
a. Lisprop(Humalog)
b. NPHp(HumulinpN)
c. Regularpinsulinp(HumulinpR)
d. Glarginep(Lantus)p-:pd.pGlarginep(Lantus)
6. Whatp isp thep therapeuticp usep ofp metformin?
A. Lowerpbloodppressure.
B. Topdiminishpseizurepactivity.
C. Thepmaintenancepofpapperson'spbloodpglucose.
D. Increasepheartpratepandpdecreasepgastrointestinalpsecretions.p-
:pC.pThepmaintenancepofpapperson'spbloodpglucose.
7. Whatpispthepcorrectpdefinitionpforpabsorptionpofpapdrug?
A. Movementpofpdrugpfrompsitepofpadministrationptopvariousptissues
pofpthepbody.
B. Describesp thep absorption,p distribution,p metabolismp &p excretionp ofp drugs
C. Theseptypespofpdrugspcanpbeptakenpoverpthepcounter.
D. Thisp addressesp howp variousp drugsp affectp differentp formsp ofp thep body:p -
pA.
Movementpofpdrugpfrompsitepofpadministrationptopvariousptissuespofp
thepbody
8. WhatpdopyoupassesspforpinpappatientpwhopisponpValproate?pSelectpallpth
papply.
A. Suicidalpthoughts
B. Monitorpforpseizures.
C. Bipolarpdisorder.
1. Whatp is/arep thep action(s)p ofp thep drugp metformin?
a. Decreasesp Hepaticp glucosep productionp andp intestinalp glucosep absorption
b. Increasesp sensitivityp top insulin
c. Shortptermpsedation
d. BothpApand:pd.pBothpApandpB
a. DecreasespHepaticpglucosepproductionpandpintestinalpglucosepabsorption
b. Increasespsensitivityptopinsulin
2. Whenp administeringp thep drugp sennap top ap patient,p ap healthp carep provider
p mustpinformptheppatientpofpwhichpofpthepfollowing
A. Thisp drugp isp intendedp top lowerp bloodp pressurep andp isp bestp
usedp inpcombination
withpotherpantihypertensives
b. Thispdrugpispnotpintendedpforplongptermpuse
c. Theppatientpmustplimitphis/herpfiberpintake
d. Advisep patientp top changep positionsp slowlyp top limitp thep ri
skp ofporthostaticphypotensionp-
:pb.pThispdrugpispnotpintendedpforplongptermpuse
3. Whenpgivingpdigoxinp(Lanoxin)ptopappatient,pthephealthpcarepproviderpnotic
espvariousp signsp andp symptomsp ofp anp overdose.p Thep healthp carep provid
erp knowspto
givep whichp ofp thep followingp top reversep digoxinp toxicity
a. Naloxone
b. VitaminpK
c. Digibind
,d. Fluemanzilp-:pc.pDigibind
4. WhilepprovidingpanpAngiotensin-
convertingpenzymep(ACE)pinhibitor,ptheppa-ptient
asks
4. whatpthepactionpofpthepdrugpis.pAspaphealthp carepprovider,p youpexplain
pthatpthepactionpofpanpACEpinhibitorpis
a. Top lowerp bloodp pressurep byp blockingp thep conversionp ofp angioten
sinp IptopvasoconstrictorpangiotensinpII
, b. Topinhibitpreabsorptionpofpsodiumpbackpintopthepbody,pultimatelypincr
easingpurinepoutputpandploweringpbloodppressure
c. Top decreasep heartp ratep andp bloodp pressurep byp competingp withp Beta
1p andpBeta2preceptorspinpthepheartpandplungs
d. Toplowerpbloodpglucosepbypstimulatingpthepreleasepofpinsulinp-
:pa.pToplowerpbloodppressurepbypblockingpthepconversionpofpangiotensinpIptopvasoconstrictor
angiotensinpII
5. Whichp ofp thep followingp typesp ofp insulinp isp "long-acting"?
a. Lisprop(Humalog)
b. NPHp(HumulinpN)
c. Regularpinsulinp(HumulinpR)
d. Glarginep(Lantus)p-:pd.pGlarginep(Lantus)
6. Whatp isp thep therapeuticp usep ofp metformin?
A. Lowerpbloodppressure.
B. Topdiminishpseizurepactivity.
C. Thepmaintenancepofpapperson'spbloodpglucose.
D. Increasepheartpratepandpdecreasepgastrointestinalpsecretions.p-
:pC.pThepmaintenancepofpapperson'spbloodpglucose.
7. Whatpispthepcorrectpdefinitionpforpabsorptionpofpapdrug?
A. Movementpofpdrugpfrompsitepofpadministrationptopvariousptissues
pofpthepbody.
B. Describesp thep absorption,p distribution,p metabolismp &p excretionp ofp drugs
C. Theseptypespofpdrugspcanpbeptakenpoverpthepcounter.
D. Thisp addressesp howp variousp drugsp affectp differentp formsp ofp thep body:p -
pA.
Movementpofpdrugpfrompsitepofpadministrationptopvariousptissuespofp
thepbody
8. WhatpdopyoupassesspforpinpappatientpwhopisponpValproate?pSelectpallpth
papply.
A. Suicidalpthoughts
B. Monitorpforpseizures.
C. Bipolarpdisorder.
